Franklin Q4 Earnings on the Deck: What's in Store for the Stock?

Franklin Templeton (BEN) is scheduled to report fiscal Q4 2026 results on Nov. 6; consensus calls for EPS of $0.78, up 16.4% year over year, and revenue of $2.36 billion, up nearly 1%. Preliminary September AUM was $1.79 trillion, including $21 billion in long-term net inflows, while the earnings model does not conclusively predict a beat and the company’s Earnings ESP is -0.65%. Clarion Partners agreed to acquire a majority stake in Stoneshield Capital, a deal expected to add $9 billion in AUM; estimates also show investment management fees down nearly 1% sequentially.

Analysis

BEN — the quality of the AUM matters more than the headline. The key read-through is whether reported flows translate into average fee-earning AUM and stable investment-management-fee yield. Month-end AUM can rise while quarterly fee revenue falls because markets, flows, product mix, and billing lags differ; the sequential fee estimate already points to that risk. A beat driven by non-recurring items or expense timing would be less durable than broad-based organic flows accompanied by controlled costs.

Near term (days): The four-quarter beat streak may leave investors focused on guidance and fee conversion, not merely EPS versus the unchanged estimate. A small negative estimate revision signal makes a clean beat less assured; an in-line print could still disappoint if expenses rise or management frames flows as concentrated or temporary.

1–3 months: Track net flows by strategy, average fee-earning AUM, investment-management-fee yield, and expense growth. The Stoneshield transaction is a platform and product-mix option, not an immediate earnings catalyst: acquired AUM does not establish the amount or timing of incremental fee revenue, and deal economics and integration costs remain to be verified.

6–18 months: Sustained private-markets fundraising could diversify BEN away from public-market sensitivity, but muted exits and cautious institutional deployment threaten fundraising conversion and performance-related revenue. Contrarian angle: headline AUM growth may overstate near-term earnings momentum; conversely, focusing only on the modest fee estimate could understate value if flows persist and alternatives scale. TROW’s reported outflows and ARES’ fee-growth model are useful industry context, not direct like-for-like comparables.

Key Decisions for Investors

• Avoid initiating a large directional position in BEN ahead of the Nov. 6 release; use the print to test fee conversion and cost discipline rather than trade the EPS beat alone.
• After results, consider a tactical BEN long only if management confirms broad-based recurring flows, average fee-earning AUM growth, and expense growth that does not consume the revenue benefit. Reassess if investment-management-fee yield weakens or flows prove concentrated.
• Treat Stoneshield as a watch item, not a standalone catalyst: verify transaction terms, expected close, fee-earning AUM contribution, and integration costs before underwriting earnings accretion.
• Falsification triggers for a constructive view: persistent net outflows, falling fee yield despite AUM growth, or expense growth that offsets revenue gains. A broad equity-market reversal would also pressure AUM and weaken the near-term thesis.